Dimethyltryptamine molecule:

Image from PubChem

DMT Clinical Trials


A Double-blind, Randomised, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of Ascending Single and Fixed Repeat Intravenous Doses of DMT in Healthy Subjects


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05559931

Organisation Name: Algernon Pharmaceuticals

Overal Status: Not yet recruiting

Start Date: November 2022

Last Update: September 29, 2022

Lead Sponsor: Algernon Pharmaceuticals

Brief Summary: This study aims to assess the safety and tolerability of single ascending, and fixed repeated doses of N,N-Dimethyltryptamine (DMT) in healthy subjects, when given by intravenous (IV) infusion.

Conditions:
  • Stroke


Total execution time in seconds: 0.30310297012329